- Home
- PTEN vs OLMA Comparison
PTEN vs OLMA Comparison
Compare PTEN & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTEN | OLMA |
|---|---|---|
| Founded | 1978 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PTEN | OLMA |
|---|---|---|
| Price | $5.91 | $27.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | $7.25 | ★ $40.50 |
| AVG Volume (30 Days) | ★ 8.0M | 2.9M |
| Earning Date | 02-04-2026 | 11-10-2025 |
| Dividend Yield | ★ 5.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,837,946,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.10 | $2.86 |
| 52 Week High | $9.58 | $36.26 |
Technical Indicators
Market Signals| Indicator | PTEN | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 46.68 | 54.52 |
| Support Level | $5.83 | $26.40 |
| Resistance Level | $6.07 | $36.26 |
| Average True Range (ATR) | 0.23 | 2.82 |
| MACD | -0.04 | -1.10 |
| Stochastic Oscillator | 19.63 | 17.20 |
Price Performance
Historical ComparisonAbout PTEN Patterson-UTI Energy Inc.
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.